NEOS Investment Management LLC Has $73.32 Million Stock Holdings in Lam Research Corporation $LRCX

NEOS Investment Management LLC raised its stake in Lam Research Corporation (NASDAQ:LRCXFree Report) by 60.6% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 547,605 shares of the semiconductor company’s stock after purchasing an additional 206,570 shares during the quarter. Lam Research accounts for about 0.5% of NEOS Investment Management LLC’s portfolio, making the stock its 27th biggest position. NEOS Investment Management LLC’s holdings in Lam Research were worth $73,324,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also bought and sold shares of the company. IMG Wealth Management Inc. purchased a new stake in Lam Research in the 2nd quarter valued at about $26,000. Howard Hughes Medical Institute bought a new position in shares of Lam Research in the second quarter valued at approximately $27,000. Sound Income Strategies LLC bought a new position in shares of Lam Research in the third quarter valued at approximately $41,000. Tripletail Wealth Management LLC bought a new stake in Lam Research during the third quarter worth $44,000. Finally, Strategic Wealth Investment Group LLC bought a new position in Lam Research during the second quarter valued at about $29,000. 84.61% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

LRCX has been the subject of a number of analyst reports. Summit Insights raised Lam Research from a “hold” rating to a “buy” rating in a report on Thursday, January 29th. Berenberg Bank raised their price objective on shares of Lam Research from $122.00 to $165.00 and gave the company a “buy” rating in a research report on Thursday, October 23rd. Bank of America boosted their price objective on shares of Lam Research from $195.00 to $245.00 and gave the company a “buy” rating in a research note on Tuesday, January 13th. Rothschild & Co Redburn raised their price target on shares of Lam Research from $225.00 to $265.00 and gave the company a “buy” rating in a report on Friday, February 6th. Finally, JPMorgan Chase & Co. boosted their price target on shares of Lam Research from $165.00 to $300.00 and gave the company an “overweight” rating in a research report on Thursday, January 29th. One analyst has rated the stock with a Strong Buy rating, twenty-eight have issued a Buy rating and six have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $244.88.

Check Out Our Latest Research Report on LRCX

Lam Research Price Performance

LRCX opened at $235.53 on Tuesday. The stock has a market capitalization of $294.12 billion, a P/E ratio of 48.26, a PEG ratio of 2.53 and a beta of 1.78. The company has a current ratio of 2.26, a quick ratio of 1.61 and a debt-to-equity ratio of 0.37. Lam Research Corporation has a 12-month low of $56.32 and a 12-month high of $251.87. The stock has a 50-day moving average price of $203.22 and a 200-day moving average price of $156.73.

Lam Research (NASDAQ:LRCXGet Free Report) last released its earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 EPS for the quarter, beating the consensus estimate of $1.17 by $0.10. Lam Research had a net margin of 30.22% and a return on equity of 62.81%. The company had revenue of $5.34 billion for the quarter, compared to analyst estimates of $5.23 billion. During the same quarter last year, the firm earned $0.91 EPS. The firm’s quarterly revenue was up 22.1% compared to the same quarter last year. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. Equities analysts predict that Lam Research Corporation will post 3.71 earnings per share for the current fiscal year.

Lam Research Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, April 8th. Stockholders of record on Wednesday, March 4th will be issued a $0.26 dividend. The ex-dividend date is Wednesday, March 4th. This represents a $1.04 annualized dividend and a dividend yield of 0.4%. Lam Research’s dividend payout ratio (DPR) is currently 21.31%.

Insider Activity at Lam Research

In related news, Director Eric Brandt sold 35,000 shares of the company’s stock in a transaction on Friday, February 6th. The shares were sold at an average price of $225.60, for a total transaction of $7,896,000.00. Following the completion of the sale, the director directly owned 253,705 shares in the company, valued at $57,235,848. This represents a 12.12% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. 0.31% of the stock is currently owned by insiders.

Lam Research Profile

(Free Report)

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.

Further Reading

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCXFree Report).

Institutional Ownership by Quarter for Lam Research (NASDAQ:LRCX)

Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.